tiprankstipranks
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market
2096
Simcere Pharmaceutical Group Limited
RESEARCH TOOLSreports

Simcere Pharmaceutical Group Limited (2096) Ratios

4 Followers

Simcere Pharmaceutical Group Limited Ratios

HK:2096's free cash flow for Q2 2025 was ¥0.81. For the 2025 fiscal year, HK:2096's free cash flow was decreased by ¥ and operating cash flow was ¥0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 2.21 2.00 2.10 1.84 1.63
Quick Ratio
 2.03 1.79 1.81 1.74 1.55
Cash Ratio
 1.06 0.71 0.75 0.56 0.32
Solvency Ratio
 0.31 0.21 0.28 0.31 0.46
Operating Cash Flow Ratio
 0.08 0.51 0.06 0.46 -0.07
Short-Term Operating Cash Flow Coverage
 0.24 1.32 0.15 1.05 -0.13
Net Current Asset Value
¥ 2.08B¥ 1.02B¥ 2.01B¥ 1.82B¥ 1.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.11 0.13 0.14 0.16
Debt-to-Equity Ratio
 0.13 0.17 0.20 0.21 0.25
Debt-to-Capital Ratio
 0.11 0.15 0.17 0.17 0.20
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.03 0.00 0.00
Financial Leverage Ratio
 1.57 1.63 1.50 1.51 1.58
Debt Service Coverage Ratio
 1.23 1.13 1.01 0.65 0.32
Interest Coverage Ratio
 18.78 12.19 20.59 25.07 20.45
Debt to Market Cap
 0.04 0.06 0.08 0.05 0.08
Interest Debt Per Share
 0.50 0.51 0.55 0.59 0.65
Net Debt to EBITDA
 -1.45 -0.54 -0.53 -0.19 1.57
Profitability Margins
Gross Profit Margin
81.61%80.25%75.43%79.08%78.40%
EBIT Margin
17.17%17.12%11.72%9.60%4.67%
EBITDA Margin
21.25%20.35%16.41%12.90%8.45%
Operating Profit Margin
16.78%12.78%10.77%13.65%28.97%
Pretax Profit Margin
19.58%12.36%11.20%14.06%28.04%
Net Profit Margin
17.38%11.05%10.82%14.73%30.14%
Continuous Operations Profit Margin
17.38%11.05%10.80%14.67%29.98%
Net Income Per EBT
88.77%89.42%96.58%104.81%107.51%
EBT Per EBIT
116.69%96.68%103.97%102.97%96.77%
Return on Assets (ROA)
9.04%6.37%6.59%8.63%14.83%
Return on Equity (ROE)
16.00%10.37%9.90%13.06%23.41%
Return on Capital Employed (ROCE)
11.29%9.66%8.71%11.03%20.41%
Return on Invested Capital (ROIC)
9.13%7.66%7.41%9.41%16.73%
Return on Tangible Assets
10.13%7.09%7.15%9.10%15.18%
Earnings Yield
4.43%4.35%4.54%3.47%7.89%
Efficiency Ratios
Receivables Turnover
 2.58 2.45 2.50 2.52 2.08
Payables Turnover
 5.86 4.75 5.12 3.94 3.33
Inventory Turnover
 2.39 2.21 2.11 4.34 4.59
Fixed Asset Turnover
 3.03 2.92 3.04 2.91 2.55
Asset Turnover
 0.52 0.58 0.61 0.59 0.49
Working Capital Turnover Ratio
 2.31 2.33 2.43 2.87 2.05
Cash Conversion Cycle
 231.62 237.62 247.90 136.21 145.11
Days of Sales Outstanding
 141.20 149.08 146.08 144.67 175.12
Days of Inventory Outstanding
 152.73 165.33 173.13 84.13 79.48
Days of Payables Outstanding
 62.32 76.79 71.31 92.59 109.49
Operating Cycle
 293.93 314.41 319.21 228.81 254.60
Cash Flow Ratios
Operating Cash Flow Per Share
 0.11 0.55 0.06 0.52 -0.08
Free Cash Flow Per Share
 0.03 0.25 -0.31 0.26 -0.16
CapEx Per Share
 0.07 0.30 0.37 0.26 0.08
Free Cash Flow to Operating Cash Flow
 0.32 0.45 -5.49 0.50 2.04
Dividend Paid and CapEx Coverage Ratio
 0.70 1.20 0.11 1.27 -0.34
Capital Expenditure Coverage Ratio
 1.48 1.82 0.15 2.00 -0.96
Operating Cash Flow Coverage Ratio
 0.22 1.15 0.11 0.90 -0.12
Operating Cash Flow to Sales Ratio
 0.03 0.21 0.02 0.21 -0.04
Free Cash Flow Yield
0.28%3.73%-5.27%2.53%-2.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 22.48 22.99 22.01 28.78 12.67
Price-to-Sales (P/S) Ratio
 4.04 2.54 2.38 4.24 3.82
Price-to-Book (P/B) Ratio
 3.18 2.39 2.18 3.76 2.97
Price-to-Free Cash Flow (P/FCF) Ratio
 360.66 26.82 -18.99 39.59 -46.42
Price-to-Operating Cash Flow Ratio
 113.29 12.12 104.18 19.78 -94.56
Price-to-Earnings Growth (PEG) Ratio
 0.44 3.10 -0.88 -0.76 0.10
Price-to-Fair Value
 3.18 2.39 2.18 3.76 2.97
Enterprise Value Multiple
 17.54 11.94 13.98 32.67 46.78
Enterprise Value
 28.70B 16.12B 15.16B 26.64B 19.76B
EV to EBITDA
 17.63 11.94 13.98 32.67 46.78
EV to Sales
 3.75 2.43 2.29 4.22 3.95
EV to Free Cash Flow
 334.77 25.65 -18.29 39.37 -48.03
EV to Operating Cash Flow
 108.63 11.59 100.35 19.67 -97.85
Tangible Book Value Per Share
 3.12 2.33 2.40 2.52 2.39
Shareholders’ Equity Per Share
 3.75 2.80 2.73 2.73 2.47
Tax and Other Ratios
Effective Tax Rate
 0.11 0.11 0.04 -0.05 -0.07
Revenue Per Share
 3.05 2.62 2.50 2.42 1.92
Net Income Per Share
 0.53 0.29 0.27 0.36 0.58
Tax Burden
 0.89 0.89 0.97 1.05 1.08
Interest Burden
 1.14 0.72 0.96 1.46 6.01
Research & Development to Revenue
 0.20 0.21 0.24 0.27 0.28
SG&A to Revenue
 0.45 0.46 0.07 0.07 0.08
Stock-Based Compensation to Revenue
 <0.01 0.01 <0.01 0.02 0.01
Income Quality
 0.36 1.70 0.20 1.53 -0.14
Currency in CNY